Could your gut hold the key to beating cancer?
NCT ID NCT04566029
Summary
This study aimed to understand why only some patients with advanced bladder cancer benefit from immunotherapy. Researchers analyzed stool and blood samples from 40 patients to see if differences in their gut bacteria could predict treatment response. The goal was to gather knowledge that could one day help doctors personalize treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Antoine Lacassagne
Nice, 06189, France
-
Centre Leon Berard
Lyon, 69373, France
-
HEGP GH Universitaire Paris Ouest
Paris, 75908, France
-
Hopital Tenon ( Paris)
Paris, Paris Cx 20, 75970, France
-
ICANS Strasbourg
Strasbourg, 67091, France
-
ICM parc euromedecine
Montpellier, Hérault, 34298, France
-
ICO-Site Paul Papin
Angers, 49055, France
-
Institut Bergonié
Bordeaux, 33076, France
-
Institut Sainte Cancerologie Lucien Neuwirth
Avignon, Saint Priest En Jarez, 42271, France
-
Iuct Oncopole
Toulouse, 31059, France
Conditions
Explore the condition pages connected to this study.